Home - READDI Making antiviral medicines to prevent another global crisis

THE RAPIDLY EMERGING ANTIVIRAL DRUG DEVELOPMENT INITIATIVE READDI IS A NONPROFIT BIOTECHNOLOGY ORGANIZATION DEDICATED TO PREVENTING GLOBAL CATASTROPHES CAUSED BY VIRUSES. IT PLAYS A CLEAR, SPECIFIC AND CENTRAL ROLE IN THE WIDELY ACCEPTED THREE-PRONGED PANDEMIC PREPAREDNESS APPROACH INVOLVING DIAGNOSTICS, THERAPEUTICS AND VACCINES. READDI DEVELOPS THERAPEUTICS.
883812342
EIN
2020
Founded
Durham, NC 27709 United States
Address
readdi.org
Web

Poslední diskuze

Nearby

Contact
Readdi Inc logo
Readdi Inc
+ Follow
14
Volunteer
4.5
Reviews
Durham
Place
About the organization

- H05 -

Medicines to Prevent Another Global Crisis READDI brings together the worlds best scientific and business minds to proactively develop safe and effective antiviral drugs BEFORE the next pandemic. Ready on Day 1 Focused on broadspectrum small molecule antivirals Connecting science to solutions 30Active Projects 96Million Invested 40Global Collaborators READDI is a core implementation partner in the 100 Days Mission a threepronged pandemic preparedness effort launched by the G7 and led by the International Pandemic Preparedness Secretariat. READDI develops therapeutics. Our Role Read about READDIs role in the latest 100 Days Mission Implementation Report.

Research Institutes and/or Public Policy Analysis
23 Vacancy More Detail